BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 26328917)

  • 1. Preoperative neutrophil-to-lymphocyte ratio predicts recurrence of patients with single-nodule small hepatocellular carcinoma following curative resection: a retrospective report.
    Liao R; Tang ZW; Li DW; Luo SQ; Huang P; Du CY
    World J Surg Oncol; 2015 Sep; 13():265. PubMed ID: 26328917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: A propensity score-based analysis.
    Yang HJ; Guo Z; Yang YT; Jiang JH; Qi YP; Li JJ; Li LQ; Xiang BD
    World J Gastroenterol; 2016 Jun; 22(21):5088-95. PubMed ID: 27275101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma.
    Goh BK; Kam JH; Lee SY; Chan CY; Allen JC; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY
    J Surg Oncol; 2016 May; 113(6):621-7. PubMed ID: 26861568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stratified neutrophil-to-lymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resection.
    Huang GQ; Zhu GQ; Liu YL; Wang LR; Braddock M; Zheng MH; Zhou MT
    Oncotarget; 2016 Feb; 7(5):5429-39. PubMed ID: 26716411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma.
    Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ
    J Surg Res; 2015 Sep; 198(1):73-9. PubMed ID: 26022997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil to lymphocyte ratio changes predict small hepatocellular carcinoma survival.
    Peng W; Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ
    J Surg Res; 2014 Dec; 192(2):402-8. PubMed ID: 24998425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Nutritional Index (PNI) Predicts Tumor Recurrence of Very Early/Early Stage Hepatocellular Carcinoma After Surgical Resection.
    Chan AW; Chan SL; Wong GL; Wong VW; Chong CC; Lai PB; Chan HL; To KF
    Ann Surg Oncol; 2015 Dec; 22(13):4138-48. PubMed ID: 25801356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation between postoperative neutrophil to lymphocyte ratio and recurrence and prognosis of hepatocellular carcinoma after radical liver resection].
    Wu XL; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):365-371. PubMed ID: 29860764
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
    Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
    Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil to lymphocyte ratio as an indicator of the malignant behaviour of hepatocellular carcinoma.
    Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Mori K; Uesaka K
    Br J Surg; 2016 Jun; 103(7):891-8. PubMed ID: 27005995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preoperative neutrophil-lymphocyte ratio as a prognostic predictor after liver transplantation for hepatocellular carcinoma].
    Wang GY; Yang Y; Zhang Q; Li H; Chen GZ; Yi SH; Xu C; Wang GS; Zhang J; Yi HM; Jiang N; Fu BS; Zhao H; Li MR; Chen YH; Cai CJ; Lu MQ; Chen GH
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(22):1519-22. PubMed ID: 21914362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis.
    Li SH; Wang QX; Yang ZY; Jiang W; Li C; Sun P; Wei W; Shi M; Guo RP
    World J Gastroenterol; 2017 May; 23(17):3122-3132. PubMed ID: 28533669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of neutrophil to lymphocyte ratio on survival for hepatocellular carcinoma after curative resection.
    Hung HC; Lee JC; Cheng CH; Wu TH; Wang YC; Lee CF; Wu TJ; Chou HS; Chan KM; Lee WC
    J Hepatobiliary Pancreat Sci; 2017 Oct; 24(10):559-569. PubMed ID: 28846835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors affecting postoperative survival of patients with solitary small hepatocellular carcinoma.
    Cai MY; Wang FW; Li CP; Yan LX; Chen JW; Luo RZ; Yun JP; Zeng YX; Xie D
    Chin J Cancer; 2016 Aug; 35(1):80. PubMed ID: 27527497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy.
    Liu Y; Wang ZX; Cao Y; Zhang G; Chen WB; Jiang CP
    Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):266-74. PubMed ID: 27298102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The elevated preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy.
    Chen Q; Yang LX; Li XD; Yin D; Shi SM; Chen EB; Yu L; Zhou ZJ; Zhou SL; Shi YH; Fan J; Zhou J; Dai Z
    Tumour Biol; 2015 Jul; 36(7):5283-9. PubMed ID: 25672606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis.
    Mano Y; Shirabe K; Yamashita Y; Harimoto N; Tsujita E; Takeishi K; Aishima S; Ikegami T; Yoshizumi T; Yamanaka T; Maehara Y
    Ann Surg; 2013 Aug; 258(2):301-5. PubMed ID: 23774313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant sorafenib therapy in patients with resected hepatocellular carcinoma: evaluation of predictive factors.
    Zhang W; Zhao G; Wei K; Zhang Q; Ma W; Wu Q; Zhang T; Kong D; Li Q; Song T
    Med Oncol; 2015 Apr; 32(4):107. PubMed ID: 25750040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI).
    Ji F; Liang Y; Fu SJ; Guo ZY; Shu M; Shen SL; Li SQ; Peng BG; Liang LJ; Hua YP
    BMC Cancer; 2016 Feb; 16():137. PubMed ID: 26907597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.